drugset
drugset / Trial / NCT01797796

Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare

NCT01797796 ↗

Phase 1 Completed 16 enrolled Pfizer
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to examine the effect of PF-06305591 on capsaicin and capsaicin/heat-induced neurogenic flare.

Timeline

Start
2013-04
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06305591 Small molecule 150 mg Oral

Indications

No indication recorded.